NOTE - 8. EQUITY

6 Months Ended

Oct. 31, 2023

Notes

NOTE - 8. EQUITY

NOTE – 8: EQUITY

Common Stock

On April 26, 2022, the Company filed an amendment to the Articles of Incorporation increasing the authorized shares of common stock to 600,000,000 with a par value of $0.0001 and the total number of preferred shares at 20,000,000, par value $0.0001.

On June 28, 2022, the Company’s common shares were reversed with each shareholder receiving one share of common stock for each 500 shares held before the reverse split. The number of shares for the three months ended January 31, 2022 and year ended April 30, 2022 have been calculated to represent the number of shares after the reverse split.

During the six months ended October 31, 2022, The Company issued 27,439 shares of common stock for the conversion of $9,000 of convertible debt.

During the six months ended October 31, 2023, the Company issued 200,000 shares of common stock with a value of $10,000 for cash.

During the six months ended October 31, 2023, the Company issued 537,081 shares of common stock for the conversion of 53,708 shares of preferred stock.

During the six months ended October 31, 2023, the Company issued 1,113,579 shares of common stock with a value of $23,016 for the conversion of debt.

Preferred Stock

The Company has 20,000,000 shares of $0.0001 par value preferred stock authorized and has designated a Series A preferred stock, a Series B preferred stock, a series C preferred stock and a series D preferred stock. The Company has authorized 5,000,000 series A and B shares each plus 1,500,000 each of series C and D preferred shares Each share of the Series A preferred stock is convertible into ten common shares and carries voting rights on the basis of 100 votes per share.  Each share of the Series B preferred stock is convertible into ten common shares and carries no voting rights. Each of the Series C preferred shares are

non-voting and are convertible to common stock as a “Blank Check” designation with terms and conditions as set by the board of directors. Each of the series D preferred shares are non-voting and may be converted into common shares as a Blank Check” designation with the terms and conditions as set forth by the board of directors.

On April 26, 2022, the Company filed an amendment to the Articles of Incorporation increasing the authorized shares of common stock to 600,000,000 with a par value of $0.0001 and the total number of preferred shares at 20,000,000, par value $0.0001.

During the six month period ended October 31, 2022, the Company issued 697,662 shares of series B preferred with for the reduction of $2,901,905 of notes payable and accrued expenses. The issuance consisted of 279,026 shares to related parties for accrued expense of $1,074,250, 53,750 shares for the payment of $322,500 of notes payable and interest and 364,886 shares for the payment of $1,505,155 of accounts payable and accrued expenses, The Company realized a loss on settlement of debt and accruals of $835,829 from the issuance of the series B preferred. The fair value of the shares issued were determined by the closing price of the number of common shares to be issued at the conversion of 10 common shares for each series B preferred share.

During the six months period ended October 31, 2022, the Company issued 50,000 shares of series B preferred for $294,992 for service.

During the six months ended October 31, 2023, the Company issued 537,081 shares of common stock for the conversion of 53,708 shares of preferred stock.

As of October 31, 2023, the Company had 4,875,655 shares of preferred stock consisting of; 2,925,369 Series A shares, 1,949,697 Series B shares and 589 Series D preferred shares issued and outstanding. The conversion price for the 589 series D shares issued is $0.50 or 80% of the lowest trading price 20 days prior to conversion.